Explore
Validate
Learn
ELISA
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60311-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- HER2/ErbB2 antibody
- Antibody type
- Monoclonal
- Description
- HER2/ErbB2 antibody (Cat. #60311-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IF, IHC,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1B12A7
- Vial size
- 20ul, 150ul
Submitted references Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients.
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer.
InvivoPen: A novel plasma source for in vivo cancer treatment.
Circulating HER-2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer.
HPK1 positive expression associated with longer overall survival in patients with estrogen receptor-positive invasive ductal carcinoma‑not otherwise specified.
Wu H, Wang W, Zhang Y, Chen Y, Shan C, Li J, Jia Y, Li C, Du C, Cai Y, Zhang Y, Zhang S, Wu F
International journal of cancer 2024 Jul 15;155(2):324-338
International journal of cancer 2024 Jul 15;155(2):324-338
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer.
Xing F, Gao H, Chen G, Sun L, Sun J, Qiao X, Xue J, Liu C
Molecular cancer 2023 Jan 10;22(1):6
Molecular cancer 2023 Jan 10;22(1):6
InvivoPen: A novel plasma source for in vivo cancer treatment.
Zhou X, Cai D, Xiao S, Ning M, Zhou R, Zhang S, Chen X, Ostrikov K, Dai X
Journal of Cancer 2020;11(8):2273-2282
Journal of Cancer 2020;11(8):2273-2282
Circulating HER-2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer.
Wu Y, Meng Q, Yang Z, Shi L, Hu R, Zhang P, Wei J, Ren J, Leng B, Xu D, Jiang GQ
Oncology letters 2018 Sep;16(3):3726-3734
Oncology letters 2018 Sep;16(3):3726-3734
HPK1 positive expression associated with longer overall survival in patients with estrogen receptor-positive invasive ductal carcinoma‑not otherwise specified.
Wang J, Song L, Yang S, Zhang W, Lu P, Li S, Li H, Wang L
Molecular medicine reports 2017 Oct;16(4):4634-4642
Molecular medicine reports 2017 Oct;16(4):4634-4642
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The HER2/ErbB2 antibody from Proteintech is a mouse monoclonal antibody to a recombinant protein of human HER2/ErbB2. This antibody recognizes human antigen. The HER2/ErbB2 antibody has been validated for the following applications: ELISA, IHC analysis.
